Abstract
We read with interest the paper by Park et al. [ [1] Park K.W. Kang S.H. Park K.H. et al. Sirolimus- vs. paclitaxel-eluting stents for the treatment of unprotected left main coronary artery stenosis: complete 2-year follow-up of a two-center registry. Int J Cardiol. 2011 Aug 18; 151: 89-95 Abstract Full Text Full Text PDF PubMed Scopus (7) Google Scholar ]. The authors conclude that, in the treatment of left main coronary artery (LMCA) stenosis, paclitaxel eluting stents (PES) and sirolimus eluting stents (SES) provide comparable 2 year-clinical results with respect to hard endpoints and major adverse cardiac events.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
